首页> 外文期刊>Transplantation: Official Journal of the Transplantation Society >Severe pancytopenia and hemophagocytosis after HHV-8 primary infection in a renal transplant patient successfully treated with foscarnet.
【24h】

Severe pancytopenia and hemophagocytosis after HHV-8 primary infection in a renal transplant patient successfully treated with foscarnet.

机译:肾移植患者成功用膦甲酰胺治疗后,HHV-8原发感染后出现严重的全血细胞减少和吞噬作用。

获取原文
获取原文并翻译 | 示例
           

摘要

We report the occurrence of human herpesvirus (HHV)-8 primary infection in an adult male kidney recipient. Four months after transplantation, the patient developed visceral Kaposi sarcoma, and 1 month later he presented with progressive and severe peripheral cytopenia, in the presence of a normocellular or hypercellular bone marrow (BM) with hemophagocytosis. HHV-8 was the sole pathogen detected by polymerase chain reaction either in the serum or in the BM. HHV-8 latent nuclear antigen was detected in immature progenitor cells from the BM. Immunosuppressive therapy was reduced, and the patient was treated with foscarnet for 2 weeks, leading to a dramatic normalization of blood cell counts, concomitantly with the disappearance of HHV-8 viremia. At the end of antiviral therapy, the patient received chemotherapy, and Kaposi sarcoma regressed in 2 months. Severe peripheral cytopenia may be a posttransplant complication after HHV-8 infection, for which treatment with foscarnet seems appropriate.
机译:我们报告了人类疱疹病毒(HHV)-8初级感染在成年男性肾脏接受者的发生。移植后四个月,患者发展为内脏卡波西肉瘤,1个月后,在正常细胞或高细胞骨髓(BM)伴有吞噬作用的情况下,患者出现进行性和严重的外周血细胞减少症。 HHV-8是在血清或BM中通过聚合酶链反应检测到的唯一病原体。在BM的未成熟祖细胞中检测到HHV-8潜在核抗原。减少了免疫抑制疗法,并用膦甲酸治疗了2周,导致血细胞计数显着正常化,并伴随着HHV-8病毒血症的消失。在抗病毒治疗结束时,患者接受了化疗,卡波西肉瘤在2个月内消退。严重的外周血细胞减少症可能是HHV-8感染后的移植后并发症,对此,采用膦甲酸治疗似乎是合适的。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号